NCT03372356Unknown不适用
Psychosocial Screening for Neuroendocrine Tumor Patients
Peking University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年8月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- DT
研究概览
简要总结
This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety and Depression Scale(HADS), Self-Perceived Burden Scale(SPBS) and Connor-Davidson Resilience Scale(CD-RISC). These assessments will be completed at baseline, 3 months, 6 months, 12 months and 24 months. Patients will have the option of filling out questionnaires more frequently if desired.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •sign written informed consent form;
- •age ≥ 18 years;
- •pathologically confirmed well-differentiated neuroendocrine tumors, G1-2 (Ki67≤20%);
排除标准
- •<18 years;
- •Neuroendocrine carcinoma;
- •History of psychiatric or psychologic illness;
- •History of previous cancers or cancer distress;
- •Patients with central nervous system(CNS) disorder；
- •Severe, uncontrolled medical condition that would affect patients' compliance;
结局指标
主要结局
DT
时间窗: every 3 month until 24 month
Distress Thermometer
次要结局
- HADS(every 3 month until 24 month)
- SPBS(every 3 month until 24 month)
- CD-RISC(every 3 month until 24 month)
研究者
Shen Lin
MD, Professor, Chief of Department of GI Oncology, Peking University Cancer Hospital
Peking University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Web-based Tailored Information and Support for Patients With a Neuroendocrine TumorNeuroendocrine TumorNCT02472678University Medical Center Groningen91
撤回
2 期
Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat EthylNeuroendocrine TumorsCarcinoid SyndromeDiarrheaNCT04713202Chandrikha Chandrasekhara
撤回
不适用
Clinical and Pathologic Studies in Neuroendocrine TumorsCarcinoid TumorNeuroendocrine TumorsNCT00657332Stanford University
已完成
不适用
Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) SyndromesMultiple Endocrine NeoplasiaNCT00501449M.D. Anderson Cancer Center133
已完成
2 期
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine TumoursNeuroendocrine TumoursNCT00326469Ipsen30